Impact case study database

The impact case study database allows you to browse and search for impact case studies submitted to the REF 2021. Use the search and filters below to find the impact case studies you are looking for.

Back

Demonstrating risks and benefits of glucose-lowering drugs in type-2 diabetes leads to new uses of these drugs in treating heart failure.

Download case study PDF

Submitting institution

University of Glasgow

Unit of assessment

1 - Clinical Medicine

Summary impact type

Health

Request cross-referral to

Is this case study continued from a case study submitted in 2014?

Underpinning research subjects

Cardiorespiratory Medicine And Haematology
Clinical Sciences
Public Health And Health Services

1. Summary of the impact

2. Underpinning research

3. References to the research

4. Details of the impact

5. Sources to corroborate the impact

Additional contextual information

Countries

United Kingdom
United States
European Union
Worldwide

Funding programmes

1) VIVIDD trial
2) ELIXA trial
3) Harmony trials
4) DAPA-HF

Global research identifiers

1) Grid.418607.c
2) Grid.417555.7
3) Grid.418236.a
4) Grid.417815.e

Name of funders

1) Novartis UK
2) Sanofi-Aventis (US)
3) GlaxoSmithKline (UK)
4) AstraZeneca (UK)

Researcher ORCIDs

0000-0002-6317-3975
0000-0003-4306-5317
0000-0002-6333-9496